Skip to main content
Erschienen in: Der Schmerz 6/2020

14.09.2020 | Migräne | Schwerpunkt

Kopfschmerz vom Spannungstyp

Quo vadis?

verfasst von: Univ. Prof. Dr. med. Andreas Straube, Stefanie Förderreuther, Ozan Emre Eren

Erschienen in: Der Schmerz | Ausgabe 6/2020

Einloggen, um Zugang zu erhalten

Zusammenfassung

Der episodische Kopfschmerz vom Spannungstyp (eSK) gilt als die häufigste Kopfschmerzform. Tritt der Kopfschmerz vom Spannungstyp an mehr als 15 Tagen im Monat in mindestens 3 aufeinanderfolgenden Monaten auf, spricht man vom chronischen Kopfschmerz vom Spannungstyp (cSK). In den letzten Jahren zeigte sich, dass gerade die Abgrenzung einer eSK-Attacke von einer leichten Migräneattacke und die Abgrenzung eines cSK von einer chronischen Migräne schwierig ist. Im Folgenden sollen Kriterien zur leichteren Abgrenzung sowie die Therapie des Kopfschmerzes vom Spannungstyp diskutiert werden. Im Weiteren werden Befunde vorgestellt, die für oder gegen eine gemeinsame Pathophysiologie (im Sinne der Konvergenzhypothese) von Kopfschmerzen vom Spannungstyp und Migräne sprechen.
Literatur
1.
Zurück zum Zitat Allais G, Chiarle G, Sinigaglia S, Mana O, Benedetto C (2019) Migraine during pregnancy and in the puerperium. Neurol Sci 40(Suppl 1):81–91PubMed Allais G, Chiarle G, Sinigaglia S, Mana O, Benedetto C (2019) Migraine during pregnancy and in the puerperium. Neurol Sci 40(Suppl 1):81–91PubMed
2.
Zurück zum Zitat Andrasik F (2010) Biofeedback in headache: an overview of approaches and evidence. Cleve Clin J Med 77(Suppl 3):72–76 Andrasik F (2010) Biofeedback in headache: an overview of approaches and evidence. Cleve Clin J Med 77(Suppl 3):72–76
3.
Zurück zum Zitat Bendtsen L (2000) Central sensitization in tension-type headache-possible pathophysiological mechanisms. Cephalalgia 20:486–508PubMed Bendtsen L (2000) Central sensitization in tension-type headache-possible pathophysiological mechanisms. Cephalalgia 20:486–508PubMed
4.
Zurück zum Zitat Bendtsen L, Jensen R (2004) Mirtazapine is effective in the prophylactic treatment of chronic tension-type headache. Neurology 62(10):1706–1711PubMed Bendtsen L, Jensen R (2004) Mirtazapine is effective in the prophylactic treatment of chronic tension-type headache. Neurology 62(10):1706–1711PubMed
5.
Zurück zum Zitat Bigal ME, Serrano D, Buse D, Scher A, Stewart WF, Lipton RB (2008) Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache 48:1157–1168PubMed Bigal ME, Serrano D, Buse D, Scher A, Stewart WF, Lipton RB (2008) Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache 48:1157–1168PubMed
6.
Zurück zum Zitat Brennum J, Kjeldsen M, Olesen J (1992) The 5‑HT1-like agonist sumatriptan has a significant effect in chronic tension-type headache. Cephalalgia 12(6):375–379PubMed Brennum J, Kjeldsen M, Olesen J (1992) The 5‑HT1-like agonist sumatriptan has a significant effect in chronic tension-type headache. Cephalalgia 12(6):375–379PubMed
7.
Zurück zum Zitat Breslau N, Schultz LR, Stewart WF, Lipton RB, Lucia VC, Welch KM (2000) Headache and major depression: is the association specific to migraine? Neurology 54(2):308–313PubMed Breslau N, Schultz LR, Stewart WF, Lipton RB, Lucia VC, Welch KM (2000) Headache and major depression: is the association specific to migraine? Neurology 54(2):308–313PubMed
8.
Zurück zum Zitat Cady RK (2007) The convergence hypothesis. Headache 47(Suppl 1):44–51 Cady RK (2007) The convergence hypothesis. Headache 47(Suppl 1):44–51
9.
Zurück zum Zitat Castien RF, van der Windt DA, Grooten A, Dekker J (2011) Effectiveness of manual therapy for chronic tension-type headache: a pragmatic, randomised, clinical trial. Cephalalgia 31(2):133–143PubMed Castien RF, van der Windt DA, Grooten A, Dekker J (2011) Effectiveness of manual therapy for chronic tension-type headache: a pragmatic, randomised, clinical trial. Cephalalgia 31(2):133–143PubMed
11.
Zurück zum Zitat Couch JR, Amitriptyline Versus Placebo Study Group (2011) Amitriptyline in the prophylactic treatment of migraine and chronic daily headache. Headache 51(1):33–51PubMed Couch JR, Amitriptyline Versus Placebo Study Group (2011) Amitriptyline in the prophylactic treatment of migraine and chronic daily headache. Headache 51(1):33–51PubMed
12.
Zurück zum Zitat Castien RF, van der Wouden JC, De Hertogh W (2018) Pressure pain thresholds over the cranio-cervical region in headache: a systematic review and meta-analysis. J Headache Pain 19(1):9PubMedPubMedCentral Castien RF, van der Wouden JC, De Hertogh W (2018) Pressure pain thresholds over the cranio-cervical region in headache: a systematic review and meta-analysis. J Headache Pain 19(1):9PubMedPubMedCentral
13.
Zurück zum Zitat Chitsaz A, Ghorbani A, Dashti M, Khosravi M, Kianmehr M (2017) The prevalence of osmophobia in migranous and episodic tension type headaches. Adv Biomed Res 2017(6):44 Chitsaz A, Ghorbani A, Dashti M, Khosravi M, Kianmehr M (2017) The prevalence of osmophobia in migranous and episodic tension type headaches. Adv Biomed Res 2017(6):44
14.
Zurück zum Zitat Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ (2007) Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. TOPMAT-MIG-201(TOP-CHROME) Study Group. Cephalalgia 27(7):814–823PubMed Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ (2007) Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. TOPMAT-MIG-201(TOP-CHROME) Study Group. Cephalalgia 27(7):814–823PubMed
15.
Zurück zum Zitat Diener HC, Pfaffenrath V, Pageler L, Peil H, Aicher B (2005) The fixed combination of acetylsalicylic acid, paracetamol and caffeine is more effective than single substances and dual combination for the treatment of headache: a multicentre, randomized, double-blind, single-dose, placebo-controlled parallel group study. Cephalalgia 25(10):776–787PubMed Diener HC, Pfaffenrath V, Pageler L, Peil H, Aicher B (2005) The fixed combination of acetylsalicylic acid, paracetamol and caffeine is more effective than single substances and dual combination for the treatment of headache: a multicentre, randomized, double-blind, single-dose, placebo-controlled parallel group study. Cephalalgia 25(10):776–787PubMed
16.
Zurück zum Zitat Do TP, Heldarskard GF, Kolding LT, Hvedstrup J, Schytz HW (2018) Myofascial trigger points in migraine and tension-type headache. J Headache Pain 19(1):84PubMedPubMedCentral Do TP, Heldarskard GF, Kolding LT, Hvedstrup J, Schytz HW (2018) Myofascial trigger points in migraine and tension-type headache. J Headache Pain 19(1):84PubMedPubMedCentral
17.
Zurück zum Zitat Dodick DW, Turkel CC, DeGryse RE, Aurora SK, Silberstein SD, Lipton RB, Diener HC, Brin MF, PREEMPT Chronic Migraine Study Group (2010) Onabotulinumtoxin A for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache 50(6):921–936PubMed Dodick DW, Turkel CC, DeGryse RE, Aurora SK, Silberstein SD, Lipton RB, Diener HC, Brin MF, PREEMPT Chronic Migraine Study Group (2010) Onabotulinumtoxin A for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache 50(6):921–936PubMed
18.
Zurück zum Zitat Fernández-de-Las-Peñas C, Fernández-Muñoz JJ, Palacios-Cena M, Parás-Bravo P, Cigarán-Méndez M, Navarro-Pardo E (2018) Sleep disturbances in tension-type headache and migraine. Ther Adv Neurol Disord 11:1–6 Fernández-de-Las-Peñas C, Fernández-Muñoz JJ, Palacios-Cena M, Parás-Bravo P, Cigarán-Méndez M, Navarro-Pardo E (2018) Sleep disturbances in tension-type headache and migraine. Ther Adv Neurol Disord 11:1–6
19.
Zurück zum Zitat Fernández-de-Las-Peñas C, Ge HY, Alonso-Blanco C, González-Iglesias J, Arendt-Nielsen L (2010) Referred pain areas of active myofascial trigger points in head, neck, and shoulder muscles, in chronic tension type headache. J Bodyw Mov Ther 14(4):391–396PubMed Fernández-de-Las-Peñas C, Ge HY, Alonso-Blanco C, González-Iglesias J, Arendt-Nielsen L (2010) Referred pain areas of active myofascial trigger points in head, neck, and shoulder muscles, in chronic tension type headache. J Bodyw Mov Ther 14(4):391–396PubMed
20.
Zurück zum Zitat Ferrari MD, Roon KI, Lipton RB, Goadsby PJ (2001) Oral triptans (serotonin 5‑HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet 358(9294):1668–1675PubMed Ferrari MD, Roon KI, Lipton RB, Goadsby PJ (2001) Oral triptans (serotonin 5‑HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet 358(9294):1668–1675PubMed
21.
Zurück zum Zitat Fuller-Thomson E, Hodgins GA (2019) Suicide attempts among those with migraine: findings from a nationally representative Canadian study. Arch Suicide Res 4:1–20 Fuller-Thomson E, Hodgins GA (2019) Suicide attempts among those with migraine: findings from a nationally representative Canadian study. Arch Suicide Res 4:1–20
22.
Zurück zum Zitat Fumal A, Schoenen J (2008) Tension-type headache: current research and clinical management. Lancet Neurol 7(1):70–83PubMed Fumal A, Schoenen J (2008) Tension-type headache: current research and clinical management. Lancet Neurol 7(1):70–83PubMed
23.
Zurück zum Zitat Gaul C, van Doorn C, Webering N, Dlugaj M, Katsarava Z, Diener HC, Fritsche G (2011) Clinical outcome of a headache-specific multidisciplinary treatment program and adherence to treatment recommendations in a tertiary headache center: an observational study. J Headache Pain 12(4):475–483PubMedPubMedCentral Gaul C, van Doorn C, Webering N, Dlugaj M, Katsarava Z, Diener HC, Fritsche G (2011) Clinical outcome of a headache-specific multidisciplinary treatment program and adherence to treatment recommendations in a tertiary headache center: an observational study. J Headache Pain 12(4):475–483PubMedPubMedCentral
24.
Zurück zum Zitat Göbel H, Fresenius J, Heinze A, Dworschak M, Soyka D (1996) Effectiveness of Oleum menthae piperitae and paracetamol in therapy of headache of the tension. Nervenarzt 67:672–681PubMed Göbel H, Fresenius J, Heinze A, Dworschak M, Soyka D (1996) Effectiveness of Oleum menthae piperitae and paracetamol in therapy of headache of the tension. Nervenarzt 67:672–681PubMed
25.
Zurück zum Zitat Haag G, Diener HC, May A, Meyer C, Morck H, Straube A, Wessely P, Evers S (2011) Self-medication of migraine and tension-type headache: summary of the evidence-based recommendations of the Deutsche Migräne und Kopfschmerzgesellschaft (DMKG), the Deutsche Gesellschaft für Neurologie (DGN), the Österreichische Kopfschmerzgesellschaft (ÖKSG) and the Schweizerische Kopfwehgesellschaft (SKG). J Headache Pain 12(2):201–217PubMed Haag G, Diener HC, May A, Meyer C, Morck H, Straube A, Wessely P, Evers S (2011) Self-medication of migraine and tension-type headache: summary of the evidence-based recommendations of the Deutsche Migräne und Kopfschmerzgesellschaft (DMKG), the Deutsche Gesellschaft für Neurologie (DGN), the Österreichische Kopfschmerzgesellschaft (ÖKSG) and the Schweizerische Kopfwehgesellschaft (SKG). J Headache Pain 12(2):201–217PubMed
26.
Zurück zum Zitat Hagen K, Stovner LJ, Zwart JA (2020) Time trends of major headache diagnoses and predictive factors. Data from three Nord-Trøndelag health surveys. J Headache Pain 21(1):24PubMedPubMedCentral Hagen K, Stovner LJ, Zwart JA (2020) Time trends of major headache diagnoses and predictive factors. Data from three Nord-Trøndelag health surveys. J Headache Pain 21(1):24PubMedPubMedCentral
27.
Zurück zum Zitat Headache Classification Committee of the International Headache Society (2018) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 38(1):1–211 Headache Classification Committee of the International Headache Society (2018) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 38(1):1–211
28.
Zurück zum Zitat Holroyd KA, O’Donnell FJ, Stensland M, Lipchik GL, Cordingley GE, Carlson BW (2001) Management of chronic tension-type headache with tricyclic antidepressant medication, stress management therapy and their combination. JAMA 285:2208–2215PubMedPubMedCentral Holroyd KA, O’Donnell FJ, Stensland M, Lipchik GL, Cordingley GE, Carlson BW (2001) Management of chronic tension-type headache with tricyclic antidepressant medication, stress management therapy and their combination. JAMA 285:2208–2215PubMedPubMedCentral
31.
Zurück zum Zitat Jackson JL, Mancuso JM, Nickoloff S, Bernstein R, Kay C (2017) Tricyclic and tetracyclic antidepressants for the prevention of frequent episodic or chronic tension-type headache in adults: a systematic review and meta-analysis. J Gen Intern Med 32(12):1351–1358PubMedPubMedCentral Jackson JL, Mancuso JM, Nickoloff S, Bernstein R, Kay C (2017) Tricyclic and tetracyclic antidepressants for the prevention of frequent episodic or chronic tension-type headache in adults: a systematic review and meta-analysis. J Gen Intern Med 32(12):1351–1358PubMedPubMedCentral
32.
Zurück zum Zitat Jensen R (1999) Pathophysiological mechanisms of tension-type headache: a review of epidemiological and experimental studies. Cephalalgia 19:602–621PubMed Jensen R (1999) Pathophysiological mechanisms of tension-type headache: a review of epidemiological and experimental studies. Cephalalgia 19:602–621PubMed
33.
Zurück zum Zitat Juang KD, Wang SJ, Fuh JL, Lu SR, Su TP (2000) Comorbidity of depressive and anxiety disorders in chronic daily headache and its subtypes. Headache 40:818–823PubMed Juang KD, Wang SJ, Fuh JL, Lu SR, Su TP (2000) Comorbidity of depressive and anxiety disorders in chronic daily headache and its subtypes. Headache 40:818–823PubMed
34.
Zurück zum Zitat Kim J, Cho SJ, Kim WJ, Yang KI, Yun CH, Chu MK (2017) Insomnia in tension-type headache: a population-based study. J Headache Pain 18(1):95PubMedPubMedCentral Kim J, Cho SJ, Kim WJ, Yang KI, Yun CH, Chu MK (2017) Insomnia in tension-type headache: a population-based study. J Headache Pain 18(1):95PubMedPubMedCentral
35.
Zurück zum Zitat Kropp P, Meyer B, Dresler T, Fritsche G, Gaul C, Niederberger U, Förderreuther S, Malzacher V, Jürgens TP, Marziniak M, Straube A (2016) Entspannungsverfahren und verhaltenstherapeutische Interventionen zur Behandlung der Migräne. Leitlinie der DMKG. Nervenheilkunde 35:502–515 Kropp P, Meyer B, Dresler T, Fritsche G, Gaul C, Niederberger U, Förderreuther S, Malzacher V, Jürgens TP, Marziniak M, Straube A (2016) Entspannungsverfahren und verhaltenstherapeutische Interventionen zur Behandlung der Migräne. Leitlinie der DMKG. Nervenheilkunde 35:502–515
37.
Zurück zum Zitat Láinez MJA, Monzón MJ (2001) Chronic daily headache. Curr Neurol Neurosci Rep 1:118–124PubMed Láinez MJA, Monzón MJ (2001) Chronic daily headache. Curr Neurol Neurosci Rep 1:118–124PubMed
38.
Zurück zum Zitat Lampl C, Marecek S, May A, Bendtsen L (2006) A prospective, open-label, long-term study of the efficacy and tolerability of topiramate in the prophylaxis of chronic tension-type headache. Cephalalgia 26(10):1203–1208PubMed Lampl C, Marecek S, May A, Bendtsen L (2006) A prospective, open-label, long-term study of the efficacy and tolerability of topiramate in the prophylaxis of chronic tension-type headache. Cephalalgia 26(10):1203–1208PubMed
39.
Zurück zum Zitat Landgraf MN, von Kries R, Heinen F, Langhagen T, Straube A, Albers L (2016) Self-reported neck and shoulder pain in adolescents is associated with episodic and chronic migraine. Cephalalgia 36(8):807–811PubMed Landgraf MN, von Kries R, Heinen F, Langhagen T, Straube A, Albers L (2016) Self-reported neck and shoulder pain in adolescents is associated with episodic and chronic migraine. Cephalalgia 36(8):807–811PubMed
41.
Zurück zum Zitat Liang Z, Galea O, Thomas L, Jull G, Treleaven J (2019) Cervical musculoskeletal impairments in migraine and tension type headache: a systematic review and meta-analysis. Musculoskelet Sci Pract 42:67–83PubMed Liang Z, Galea O, Thomas L, Jull G, Treleaven J (2019) Cervical musculoskeletal impairments in migraine and tension type headache: a systematic review and meta-analysis. Musculoskelet Sci Pract 42:67–83PubMed
42.
Zurück zum Zitat Lieba-Samal D, Wöber C (2011) Sex Hormones and primary headache other than migraine. Curr Pain Headache Rep 15(5):407–414PubMed Lieba-Samal D, Wöber C (2011) Sex Hormones and primary headache other than migraine. Curr Pain Headache Rep 15(5):407–414PubMed
43.
Zurück zum Zitat Linde K, Allais G, Brinkhaus B, Manheimer E, Vickers A, White AR (2009) Acupuncture for tension-type headache. Cochrane Database Syst Rev 21(1):CD7587 Linde K, Allais G, Brinkhaus B, Manheimer E, Vickers A, White AR (2009) Acupuncture for tension-type headache. Cochrane Database Syst Rev 21(1):CD7587
44.
Zurück zum Zitat Lipton RB, Cady RK, Stewart WF, Wilks K, Hall C (2002) Diagnostic lessons from the spectrum study. Neurology 58(9 Suppl 6):S27–S31PubMed Lipton RB, Cady RK, Stewart WF, Wilks K, Hall C (2002) Diagnostic lessons from the spectrum study. Neurology 58(9 Suppl 6):S27–S31PubMed
45.
Zurück zum Zitat Mathew NT, Reuveni U, Perez F (1987) Transformed or evolutive migraine. Headache 27(2):102–106PubMed Mathew NT, Reuveni U, Perez F (1987) Transformed or evolutive migraine. Headache 27(2):102–106PubMed
46.
Zurück zum Zitat Melchart D, Streng A, Hoppe A, Brinkhaus B, Wit C, Wagenpfeil S, Pfaffenrath V, Hammes M, Hummelsberger J, Irnich D, Weidenhamme W, Willich SN, Linde A (2005) Acupuncture in patients with tension-type headache: randomised controlled trial. BMJ 331(7513):376–382PubMedPubMedCentral Melchart D, Streng A, Hoppe A, Brinkhaus B, Wit C, Wagenpfeil S, Pfaffenrath V, Hammes M, Hummelsberger J, Irnich D, Weidenhamme W, Willich SN, Linde A (2005) Acupuncture in patients with tension-type headache: randomised controlled trial. BMJ 331(7513):376–382PubMedPubMedCentral
47.
Zurück zum Zitat Merikangas KR, Cui L, Richardson AK, Isler H, Khoromi S, Nakamura E, Lamers F, Rössler W, Ajdacic-Gross V, Gamma A, Angst J (2011) Magnitude, impact, and stability of primary headache subtypes: 30 year prospective Swiss cohort study. BMJ 343:d5076PubMedPubMedCentral Merikangas KR, Cui L, Richardson AK, Isler H, Khoromi S, Nakamura E, Lamers F, Rössler W, Ajdacic-Gross V, Gamma A, Angst J (2011) Magnitude, impact, and stability of primary headache subtypes: 30 year prospective Swiss cohort study. BMJ 343:d5076PubMedPubMedCentral
48.
Zurück zum Zitat Min YW, Lee JH, Min BH, Lee JH, Kim JJ, Chung CS, Rhee PL (2013) Clinical predictors for migraine in patients presenting with nausea and/or vomiting. J Neurogastroenterol Motil 19(4):516–520PubMedPubMedCentral Min YW, Lee JH, Min BH, Lee JH, Kim JJ, Chung CS, Rhee PL (2013) Clinical predictors for migraine in patients presenting with nausea and/or vomiting. J Neurogastroenterol Motil 19(4):516–520PubMedPubMedCentral
49.
Zurück zum Zitat Müller B, Dresler T, Gaul C, Glass Ä, Jürgens TP, Kropp P, Ruscheweyh R, Straube A, Förderreuther S (2019) More attacks and analgesic use in old age: self-reported headache across the lifespan in a German sample. Front Neurol 10:1000PubMedPubMedCentral Müller B, Dresler T, Gaul C, Glass Ä, Jürgens TP, Kropp P, Ruscheweyh R, Straube A, Förderreuther S (2019) More attacks and analgesic use in old age: self-reported headache across the lifespan in a German sample. Front Neurol 10:1000PubMedPubMedCentral
50.
Zurück zum Zitat Oguz Akarsu E, Baykan B, Ertas M, Zarifoglu M, Orhan EK, Saip S, Siva A, Karli N, Turkish Headache Study Group (2020) The persistence versus interchangeability of migraine and tension-type headaches in a 5-year population-based validated survey. Cephalalgia 40(1):39–48PubMed Oguz Akarsu E, Baykan B, Ertas M, Zarifoglu M, Orhan EK, Saip S, Siva A, Karli N, Turkish Headache Study Group (2020) The persistence versus interchangeability of migraine and tension-type headaches in a 5-year population-based validated survey. Cephalalgia 40(1):39–48PubMed
51.
Zurück zum Zitat Pfaffenrath V, Fendrich K, Vennemann M, Meisinger C, Ladwig KH, Evers S, Straube A, Hoffmann W, Berger K (2009) Regional variations in the prevalence of migraine and tension-type headache applying the new IHS criteria: the German DMKG Headache Study. Cephalalgia 29(1):48–57PubMed Pfaffenrath V, Fendrich K, Vennemann M, Meisinger C, Ladwig KH, Evers S, Straube A, Hoffmann W, Berger K (2009) Regional variations in the prevalence of migraine and tension-type headache applying the new IHS criteria: the German DMKG Headache Study. Cephalalgia 29(1):48–57PubMed
52.
Zurück zum Zitat Rossi P, Vollono C, Valeriani M, Sandrini G (2011) The contribution of clinical neurophysiology to the comprehension of the tension-type headache mechanisms. Clin Neurophysiol 122(6):1075–1085PubMed Rossi P, Vollono C, Valeriani M, Sandrini G (2011) The contribution of clinical neurophysiology to the comprehension of the tension-type headache mechanisms. Clin Neurophysiol 122(6):1075–1085PubMed
55.
Zurück zum Zitat Scher AI, Stewart WF, Ricci JA, Lipton RB (2003) Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain 106(1/2):81–89PubMed Scher AI, Stewart WF, Ricci JA, Lipton RB (2003) Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain 106(1/2):81–89PubMed
56.
Zurück zum Zitat Schmidt-Wilcke T, Leinisch E, Straube A, Kampfe N, Draganski B, Diener HC, Bogdahn U, May A (2005) Gray matter decrease in patients with chronic tension type headache. Neurology 65(9):1483–1486PubMed Schmidt-Wilcke T, Leinisch E, Straube A, Kampfe N, Draganski B, Diener HC, Bogdahn U, May A (2005) Gray matter decrease in patients with chronic tension type headache. Neurology 65(9):1483–1486PubMed
57.
Zurück zum Zitat Schulte-Mattler WJ, Krack P, BoNTTH Study Group (2004) Treatment of chronic tension-type headache with botulinum toxin A: a randomized, double-blind, placebo-controlled multicenter study. Pain 109(1/2):110–114PubMed Schulte-Mattler WJ, Krack P, BoNTTH Study Group (2004) Treatment of chronic tension-type headache with botulinum toxin A: a randomized, double-blind, placebo-controlled multicenter study. Pain 109(1/2):110–114PubMed
58.
Zurück zum Zitat Seo JG, Kim KT, Moon HJ, Kuk Do J, Kim SY, Park SP (2019) Suicidality and its risk factors in tension-type headache patients: a multicenter case-control study. J Clin Neurosci 69:21–25PubMed Seo JG, Kim KT, Moon HJ, Kuk Do J, Kim SY, Park SP (2019) Suicidality and its risk factors in tension-type headache patients: a multicenter case-control study. J Clin Neurosci 69:21–25PubMed
60.
Zurück zum Zitat Stovner LJ, Andree C (2010) Prevalence of headache in Europe: a review for the Eurolight project. J Headache Pain 11(4):289–299PubMedPubMedCentral Stovner LJ, Andree C (2010) Prevalence of headache in Europe: a review for the Eurolight project. J Headache Pain 11(4):289–299PubMedPubMedCentral
61.
Zurück zum Zitat Straube A et al (2015) Therapie des episodischen und chronischen Kopfschmerzes vom Spannungstyp und anderer chronischer täglicher Kopfschmerzen (Herausgegeben von der Kommission Leitlinien der Deutschen Gesellschaft für Neurologie sowie der Deutschen Migräne und Kopfschmerz Gesellschaft März 2015; www.dgn.org; www.dmkg.org; www.awmf.de. Zugegriffen: 25. Juni 2020) Straube A et al (2015) Therapie des episodischen und chronischen Kopfschmerzes vom Spannungstyp und anderer chronischer täglicher Kopfschmerzen (Herausgegeben von der Kommission Leitlinien der Deutschen Gesellschaft für Neurologie sowie der Deutschen Migräne und Kopfschmerz Gesellschaft März 2015; www.​dgn.​org; www.​dmkg.​org; www.​awmf.​de. Zugegriffen: 25. Juni 2020)
63.
Zurück zum Zitat Straube A (2010) Botulinumtoxin bei Kopfschmerzen: Ende eines langen Weges? Akt Neurol 37:327–332 Straube A (2010) Botulinumtoxin bei Kopfschmerzen: Ende eines langen Weges? Akt Neurol 37:327–332
64.
Zurück zum Zitat Torelli P, Jensen R, Olesen J (2004) Physiotherapy for tension-type headache: a controlled study. Cephalalgia 24(1):29–36PubMed Torelli P, Jensen R, Olesen J (2004) Physiotherapy for tension-type headache: a controlled study. Cephalalgia 24(1):29–36PubMed
65.
Zurück zum Zitat Vuralli D, Boran HE, Cengiz B, Coskun O, Bolay H (2017) Somatosensory temporal discrimination remains intact in tension-type headache whereas it is disrupted in migraine attacks. Cephalalgia 37(13):1241–1247PubMed Vuralli D, Boran HE, Cengiz B, Coskun O, Bolay H (2017) Somatosensory temporal discrimination remains intact in tension-type headache whereas it is disrupted in migraine attacks. Cephalalgia 37(13):1241–1247PubMed
66.
Zurück zum Zitat Wallasch TM, Kropp P (2012) Multidisciplinary integrated headache care: a prospective 12-month follow-up observational study. J Headache Pain 13(7):521–529PubMedPubMedCentral Wallasch TM, Kropp P (2012) Multidisciplinary integrated headache care: a prospective 12-month follow-up observational study. J Headache Pain 13(7):521–529PubMedPubMedCentral
68.
Zurück zum Zitat Yoon MS, Katsarava Z, Obermann M, Fritsche G, Oezyurt M, Kaesewinkel K, Katsarova A, Santowski I, Diener H, Moebus S (2012) Prevalence of primary headaches in Germany: results of the German Headache Consortium Study. J Headache Pain 13(3):215–223PubMedPubMedCentral Yoon MS, Katsarava Z, Obermann M, Fritsche G, Oezyurt M, Kaesewinkel K, Katsarova A, Santowski I, Diener H, Moebus S (2012) Prevalence of primary headaches in Germany: results of the German Headache Consortium Study. J Headache Pain 13(3):215–223PubMedPubMedCentral
69.
Zurück zum Zitat Yu S, Han X (2015) Update of chronic tension-type headache. Curr Pain Headache Rep 19(1):469PubMed Yu S, Han X (2015) Update of chronic tension-type headache. Curr Pain Headache Rep 19(1):469PubMed
70.
Zurück zum Zitat Zissis NP, Harmoussi S, Vlaikidis N, Mitsikostas D, Thomaidis T, Georgiadis G, Karageorgiou KA (2007) A randomized, double-blind, placebo-controlled study of venlafaxine XR in out-patients with tension-type headache. Cephalalgia 27(4):315–324PubMed Zissis NP, Harmoussi S, Vlaikidis N, Mitsikostas D, Thomaidis T, Georgiadis G, Karageorgiou KA (2007) A randomized, double-blind, placebo-controlled study of venlafaxine XR in out-patients with tension-type headache. Cephalalgia 27(4):315–324PubMed
Metadaten
Titel
Kopfschmerz vom Spannungstyp
Quo vadis?
verfasst von
Univ. Prof. Dr. med. Andreas Straube
Stefanie Förderreuther
Ozan Emre Eren
Publikationsdatum
14.09.2020
Verlag
Springer Medizin
Erschienen in
Der Schmerz / Ausgabe 6/2020
Print ISSN: 0932-433X
Elektronische ISSN: 1432-2129
DOI
https://doi.org/10.1007/s00482-020-00495-5

Weitere Artikel der Ausgabe 6/2020

Der Schmerz 6/2020 Zur Ausgabe

Einführung zum Thema

Primäre Kopfschmerzen

President‘s Corner (Mitteilungen der SPS)

President's Corner (Mitteilungen der SPS)

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.